Literature DB >> 25311657

Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance.

D Hongo1, X Tang, J Baker, E G Engleman, S Strober.   

Abstract

The goal of the study was to elucidate the cellular and molecular mechanisms by which a clinically applicable immune tolerance regimen of combined bone marrow and heart transplants in mice results in mixed chimerism and graft acceptance. The conditioning regimen of lymphoid irradiation and anti-T cell antibodies changed the balance of cells in the lymphoid tissues to create a tolerogenic microenvironment favoring the increase of natural killer T (NKT) cells, CD4+ CD25+ regulatory T cells and Gr-1+ CD11b+ myeloid-derived suppressor cells (MDSCs), over conventional T cells (Tcons). The depletion of MDSCs abrogated chimerism and tolerance, and add back of these purified cells was restorative. The conditioning regimen activated the MDSCs as judged by the increased expression of arginase-1, IL-4Rα and programmed death ligand 1, and the activated cells gained the capacity to suppress the proliferation of Tcons to alloantigens in the mixed leukocyte reaction. MDSC activation was dependent on the presence of host invariant NKT cells. The conditioning regimen polarized the host invariant NKT cells toward IL-4 secretion, and MDSC activation was dependent on IL-4. In conclusion, there was a requirement for MDSCs for chimerism and tolerance, and their suppressive function was dependent on their interactions with NKT cells and IL-4. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Basic (laboratory) research/science; bone marrow/hematopoietic stem cell transplantation; immunosuppression/immune modulation; immunosuppressive regimens; induction; macrophage/monocyte biology: activation; tolerance: chimerism; tolerance: mechanisms

Mesh:

Year:  2014        PMID: 25311657      PMCID: PMC4205183          DOI: 10.1111/ajt.12914

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  46 in total

1.  Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy.

Authors:  D K Trager; B A Banks; G E Rosenbaum; B I Holm; J A Shizuru; S Strober; C G Fathman
Journal:  Transplantation       Date:  1989-04       Impact factor: 4.939

2.  Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion.

Authors:  Masanori Higuchi; Defu Zeng; Judith Shizuru; Jennifer Gworek; Sussan Dejbakhsh-Jones; Masaru Taniguchi; Samuel Strober
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

3.  Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.

Authors:  F Lan; D Zeng; M Higuchi; P Huie; J P Higgins; S Strober
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

4.  Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells.

Authors:  S T Smiley; M H Kaplan; M J Grusby
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

5.  B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.

Authors:  Jun Konishi; Koichi Yamazaki; Miyuki Azuma; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

6.  Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.

Authors:  Christian Blank; Ian Brown; Reinhard Marks; Hiroyuki Nishimura; Tasuku Honjo; Thomas F Gajewski
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

7.  Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.

Authors:  Fengshuo Lan; Defu Zeng; Masanori Higuchi; John P Higgins; Samuel Strober
Journal:  Biol Blood Marrow Transplant       Date:  2003-06       Impact factor: 5.742

Review 8.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 9.  Tissue expression, structure and function of the murine Ly-6 family of molecules.

Authors:  T P Gumley; I F McKenzie; M S Sandrin
Journal:  Immunol Cell Biol       Date:  1995-08       Impact factor: 5.126

10.  Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Authors:  Masaki Terabe; So Matsui; Jong-Myun Park; Mizuko Mamura; Nancy Noben-Trauth; Debra D Donaldson; Wanjun Chen; Sharon M Wahl; Steven Ledbetter; Bruce Pratt; John J Letterio; William E Paul; Jay A Berzofsky
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

Review 2.  Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.

Authors:  Joseph R Scalea; Young Suk Lee; Eduardo Davila; Jonathan S Bromberg
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

3.  Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes.

Authors:  Giuliana Guggino; Cristiano Scottà; Giovanna Lombardi; Francesco Dieli; Guido Sireci
Journal:  Cell Mol Immunol       Date:  2015-04-06       Impact factor: 11.530

Review 4.  Path to clinical transplantation tolerance and prevention of graft-versus-host disease.

Authors:  Samuel Strober
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

5.  The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.

Authors:  Chenlu Han; Tingting Wu; Ning Na; Yang Zhao; Weiguo Li; Yong Zhao
Journal:  Inflamm Res       Date:  2016-05-04       Impact factor: 4.575

6.  Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

Authors:  David Hongo; Xiaobin Tang; Xiangyue Zhang; Edgar G Engleman; Samuel Strober
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

7.  In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid-Derived Suppressor Cells.

Authors:  A F Zahorchak; M B Ezzelarab; L Lu; H R Turnquist; A W Thomson
Journal:  Am J Transplant       Date:  2015-09-15       Impact factor: 8.086

Review 8.  Stable mixed chimerism and tolerance to human organ transplants.

Authors:  Samuel Strober
Journal:  Chimerism       Date:  2016-02-08

9.  Regulatory T Cell Immunotherapy in Immune-Mediated Diseases.

Authors:  Antonio Pierini; Dominik Schneidawind; Hidekazu Nishikii; Robert S Negrin
Journal:  Curr Stem Cell Rep       Date:  2015-09-12

10.  TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide.

Authors:  Fan Yang; Yang Li; Tingting Wu; Ning Na; Yang Zhao; Weiguo Li; Chenlu Han; Lianfeng Zhang; Jun Lu; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2016-03-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.